antibiotics on glp 1 What to do if you miss a dose of GLP-1 Naval Ravikant drops a perspective
Description
T2: Payer resistance
Patients who regained 1% of their body weight after discontinuation were significantly more likely to restart GLP-1 RA therapy, with hazard increases of 2.3% for those with Type 2 diabetes and 2.8% for those without

"People with type 2 diabetes are four times as likely to be hospitalized for heart failure, and repeated hospitalizations lead to worse outcomes, making treatment options that improve clinical outcomes crucial," said Mohamed Eid, M.D., M.P.H., M.H.A., vice president, Clinical Development & Medical Affairs, Cardio-Metabolism & Respiratory Medicine, Boehringer Ingelheim Pharmaceuticals, Inc
31 This finding is regarded as of paramount importance in the long-term clinical care of patients with T2DM

Barrea L, Pugliese G, Muscogiuri G, Laudisio D, Colao A, Savastano S
